Welcome to
The information on this site is tailored to Florida healthcare providers under Senate Bill SB1768.
By continuing, you confirm that:
You understand the material is intended for Florida physicians only.
The information on this site is tailored to Florida healthcare providers under Senate Bill SB1768.
By continuing, you confirm that:
You understand the material is intended for Florida physicians only.
Dr. George C. Shapiro, MD, FACC is Chief Medical Officer of ZeoScientifiX and a board-certified physician in Internal Medicine and Cardiovascular Disease.
He is also a co-founder and former Chief Medical Innovation Officer of Fountain Life, where he helped develop a precision longevity platform integrating advanced diagnostics and biologic therapies.
Dr. Shapiro is a former Assistant Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and has held additional academic appointments at NYU School of Medicine and New York Medical College.
With more than 35 years of clinical experience, his work focuses on regenerative biologics, extracellular vesicle therapeutics, and biomarker-driven approaches to improving human healthspan.
He completed his fellowship in Cardiovascular Disease at Columbia University College of Physicians and Surgeons and his internship and residency in Internal Medicine at Albert Einstein College of Medicine, with clinical training at Jacobi Medical Center and Montefiore Medical Center. He has also served as an Attending Physician at NewYork-Presbyterian Hospital.
Dr. Shapiro has served as Principal Investigator or investigator on multiple FDA-regulated clinical studies, including IND-authorized Phase I/II trials evaluating extracellular vesicle biologics across indications such as COVID-19 respiratory disease, chronic obstructive pulmonary disease, osteoarthritis, traumatic brain injury, and post-viral inflammatory syndromes. His work focuses on translating emerging biologic science into clinically deployable therapies targeting the underlying mechanisms of aging.
He is a recognized leader in age management and regenerative medicine and previously served as President and Medical Director of Cenegenics New York City, where he led one of the nation’s premier age-management practices. He is the recipient of the Alan P. Mintz, MD Award for Clinical Excellence in Age Management Medicine and is a frequent faculty speaker for A4M and AMMG.
Dr. Shapiro is also a contributor to Life Force (Tony Robbins and Peter Diamandis) and served as Executive Producer of the documentaries Longevity Hackers and Longevity Revolution. His current work focuses on advancing next-generation biologic platforms designed to modulate cellular signaling, restore tissue function, and target the biology of aging.
ZEO ScientifiXTM supplies biologic products that let Florida physicians treat pain, orthopedics, and wound care with regulatory confidence.*
*Senate Bill 1768 became law in Florida on July 1, 2025 and amended FS §458.3245 and FS§459.0127, making stem cell therapies, as defined in the statute, available for the following therapeutic indications: orthopedics, wound care, and pain management.
*The material on this site is intended for general informational and educational purposes only and is not intended to provide medical advice, diagnosis, or treatment recommendations. ZEO ScientifiX doesn’t make any medical claims regarding any of these products. ZEO ScientifiX does not offer medical services to the public and does not endorse or guarantee any third-party products or services referenced. Content may reference investigational biologics or devices not approved by the FDA. If you are a patient please consult your physician for further information. Any mention of product usage are for therapeutic use only in the states of Florida and Utah. Certain information provided herein is intended only for those that may fall under the new Florida stem cell law in effect as of July 1, 2025. Subject to change without notice.
